The role of viral respiratory infections in the pathogenesis and exacerbation of asthma

Seminars in Respiratory Infections

Volumn 18, Issue 1, 2003, Pages 3-8

  Cohen, Lance ^a   Castro, Mario ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RIBAVIRIN; RIMANTADINE; ZANAMIVIR;

ADOLESCENT; ADULT; AEROSOL; ASTHMA; BRONCHIOLITIS; CHILD; DISEASE EXACERBATION; DRUG EFFICACY; EPITHELIUM CELL; HIGH RISK PATIENT; HUMAN; IMMUNE SYSTEM; INFANT; INFLAMMATION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; NONHUMAN; PARAINFLUENZA VIRUS; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; VIRUS INFECTION;

ASTHMA; HUMANS; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 0037349872     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2003.50001     Document Type: Review

References (44)

1. Centers for Disease Control and Prevention: CDC Surveillance Summaries. Surveillance for asthma-United States, 1960-1995. MMWR Morb Mortal Wkly Rep 47:1-27, 1998
2. Castro M, Schechtman K, Halstead J, et al: Risk factors for asthma morbidity and mortality in a large metropolitan city. J Asthma 38:625-636, 2001
3. National Institutes of Health: National Heart Lung, and Blood Institute: Data Fact Sheet: Asthma Statistics. Bethesda, MD: U.S. Department of Health and Human Services, 1999
4. Krawiec ME, Westcott JY, Chu HW, et al: Persistent wheezing in very young children is associated with lower respiratory inflammation [see comments]. Am J Respir Crit Care Med 163:1338-1343, 2001
5. Long CE, McBride JT, Hall CB: Sequelae of respiratory syncytial virus infections. A role for intervention studies. Am J Respir Crit Care Med 151:1678-1680, 1995
6. Martinez FD, Morgan WJ, Wright AL, et al: Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 319:1112-1117, 1988
7. Moylett EHPP: Respiratory syncytial virus infection: Diagnosis, treatment, and prevention. Hosp Med 35:10-17, 1999
8. Sims DG, Downham MA, Gardner PS, et al: Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. BMJ 1:11-14, 1978
9. Pullan CR, Hey EN: Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. BMJ 284:1665-1669, 1982
10. Murray M, Webb MS, O'Callaghan C, et al: Respiratory status and allergy after bronchiolitis. Arch Dis Child 67:482-487, 1992
11. Noble V, Murray M, Webb MS, et al: Respiratory status and allergy nine to 10 years after acute bronchiolitis. Arch Dis Child 76:315-319, 1997
12. Sigurs N, Bjarnason R, Sigubergsson F, et al: Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls. Pediatrics 95:500-505, 1995
13. Sigurs N, Bjarnason R, Sigurbergsson F, et al: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161:1501-1507, 2000
14. Welliver RC, Duffy L: The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 15:19-27, 1993
15. Forster J, Tacke U, Krebs H, et al: Respiratory syncytial virus infection: Its role in aeroallergen sensitization during the first two years of life. Pediatr Allergy Immunol 7:55-60, 1996
16. Shaheen SO, Aaby P, Hall AJ, et al: Measles and atopy in Guinea-Bissau [see comments]. Lancet 347:1792-1796, 1996
17. Matricardi PM, Rosmini F, Ferrigno L, et al: Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus [see comments]. BMJ 314:999-1003, 1997
18. Cheung D, Dick E, Timmers M, et al: Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 152:1490-1496, 1995
19. Summers QA, Higgins PG, Barrow IG, et al: Bronchial reactivity to histamine and bradykinin is unchanged after rhinovirus infection in normal subjects. Eur Respir J 5:313-317, 1992
20. Gern J, Calhoun W, Swenson C, et al: Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 155:1872-1876, 1997
21. Folkerts G, Busse W, Nijkamp F, et al: Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 157:1708-1720, 1998
22. Fryer AD, el-Fakahany EE, Jacoby DB: Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart. Eur J Pharmacol 181: 51-58, 1990
23. Empey DW, Laitinen LA, Jacobs L, et al: Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 113:131-139, 1976
24. Kowalski ML, Didier A, Kaliner MA: Neurogenic inflammation in the airways. I. Neurogenic stimulation induces plasma protein extravasation into the rat airway lumen. Am Rev Respir Dis 140:101-109, 1989
25. Piedimonte G, Hoffman JI, Husseini WK, et al: NK1 receptors mediate neurogenic inflammatory increase in blood flow in rat airways. J Applied Physiol 74:2462-2468, 1993
26. Ladenius AR, Folkerts G, van der Linde HJ, et al: Potentiation by viral respiratory infection of ovalbumin-induced guinea-pig tracheal hyperresponsiveness: Role for tachykinins. Br J Pharmacol 115:1048-1052, 1995
27. Fraenkel D, Bardin P, Sanderson G, et al: Immunohistochemical analysis of nasal biopsies during rhinovirus experimental colds. Am J Respir Crit Care Med 150:1130-1136, 1994
28. Becker S, Quay J, Soukup J: Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 147: 4307-4312, 1991
29. Becker S, Koren HS, Henke DC: Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Respir Cell Mol Biol 8:20-27, 1993
30. Noah TL, Becker S: Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 265:L472-L478, 1993
31. Tosi M, Stark J, Hamedani A, et al: Intercellular adhesion molecule-1 (ICAM-1)-dependent and ICAM-1-independent adhesive interactions between polymorphonuclear leukocytes and human airway epithelial cells infected with parainfluenza virus type 2. J Immunol 149:3345-3349, 1992
32. Stark J, Godding V, Sedgwick J, et al: Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. J Immunol 156: 4774-4782, 1996
33. Pilewski J, Sott D, Wilson J, et al: ICAM-1 expression in bronchial epithelium after recombinant adenovirus infection. Am J Respir Cell Mol Biol 12:142-148, 1995
34. Delves P, Roitt E: The immune system. N Engl J Med 343:37-49, 2000
35. Kimpen JL: Respiratory syncytial virus and asthma. The role of monocytes. Am J Respir Crit Care Med 163:7-9, 2001 (suppl)
36. Openshaw PJ, O'Donnell DR: Asthma and the common cold: Can viruses imitate worms? Thorax 49:101-103, 1994
37. Castro M for The American Lung Association Asthma Clinical Research Centers: Safety of inactivated influenza vaccine in children and adults with asthma. N Engl J Med 345: 1529-1536, 2001
38. Bacharier L, Jenkerson M, Tegtmeier L, et al: Pulmonary function in infants following hospitalization for respiratory syncytial virus (RSV) bronchiolitis. Am J Respir Crit Care Med 2003 (in press)
39. Richter H, Seddon P: Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatrics 132:849-853, 1998
40. Fox GF, Everard ML, Marsh MJ, et al: Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child 80:343-347, 1999
41. Kajosaari M, Syvanen P, Forars M, et al: Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma. Pediatr Allergy Immunol 11:198-202, 2000
42. Krilov LR, Mandel FS, Barone SR, et al: Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: Potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group. Pediatr Infect Dis J 16:273-276, 1997
43. Long CE, Voter KZ, Barker WH, et al: Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo. Pediatr Infect Dis J 16:1023-1028, 1997
44. Gern JE: Viral and bacterial infections in the development and progression of asthma. J Allergy Clin Immunol 105: 497-502, 2000 (suppl)